February 2026 AstraZeneca prices a $2bn bond offering AstraZeneca PLC ("AstraZeneca") announces that its wholly owned subsidiary AstraZeneca Finance LLC, priced a three tranche global bond offering ...

AstraZeneca announced on Thursday that it plans to invest more than 100 billion yuan ($15 billion) in China by 2030 to expand its pharmaceutical manufacturing and research and development footprint.

Evinova today announced strategic collaborations with global life sciences companies Astellas Pharma Inc. ("Astellas"), AstraZeneca and Bristol Myers Squibb to accelerate their global clinical develop ...

At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.

XLV gains, top S&P 500 winners/losers, and key earnings & deal news on AstraZeneca, CVS, Moderna & Lilly—read now.

WILMINGTON, DE — AstraZeneca began trading its ordinary shares on the New York Stock Exchange on Monday, February 2, 2026, marking a significant milestone as the global biopharmaceutical giant expands ...

This is Part 4 of a four-part series exploring how the brain generates meaning. In Parts 1, 2, and 3 of this series, I traced meaning from biological significance through neural mechanisms to symbolic ...

AstraZeneca AZN2.39%increase; green up pointing triangle expects continued sales growth this year and restated its ambitious 2030 revenue target of $80 billion as it posted a surge in emerging-market ...

AstraZeneca’s chief executive on Tuesday teased the prospect of a weight-loss drug in development that the company moved into late-stage trials. The company said it’s starting a Phase III program on ...

AstraZeneca PLC (NASDAQ:AZN) is one of the stocks in focus on Jim Cramer’s game plan. Cramer mentioned the company during the episode and said: On Tuesday, we’re back in heavy earnings rotation. We’ve ...

AstraZeneca (NASDAQ:AZN) will release its quarterly earnings report on Tuesday, 2026-02-10. Here's a brief overview for investors ahead of the announcement. Analysts anticipate AstraZeneca to report ...